As big pharma faces government and public scrutiny, many pharmaceutical companies are seeing an uptick in litigation, driving an increased emphasis and need for cost savings so they can focus on what they do best — developing and manufacturing medicine to improve the health and wellbeing of patients. Hiring attorneys to review large quantities of documents is one of the costliest aspects of any litigation. One Fortune 100 pharmaceutical company discovered a better way to manage rising litigation costs with the help of Integreon, an alternative legal service provider (ALSP).